Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.
Application of TGF beta 1 (10-100 ng) to the chicken chorioallantoic membrane (CAM) for 72 h resulted in a dose-dependent, gross angiogenic response. The vascular effects induced by TGF beta 1 were qualitatively different than those induced by maximal doses of basic FGF (bFGF) (500 ng). While TGF beta 1 induced the formation of large blood vessels by 72 h, bFGF induced primarily small blood vessels. Histologic analysis revealed that TGF beta 1 stimulated pleiotropic cellular responses in the CAM. Increases in fibroblast and epithelial cell density in the area of TGF beta 1 delivery were observed as early as 4 h after TGF beta 1 treatment. By 8 h, these cell types also demonstrated altered morphology and marked inhibition of proliferation as evidenced by 3H-thymidine labeling. Thus, the TGF beta 1-stimulated accumulation of these cell types was the result of cellular chemotaxis from peripheral areas into the area of TGF beta 1 delivery. Microscopic angiogenesis in the form of capillary sprouts and increased endothelial cell density first became evident at 16 h. By 24 h, capillary cords appeared within the mesenchyme of the CAM, extending towards the point of TGF beta 1 delivery. 3H-thymidine labeling revealed that the growth of these capillary cords was due to endothelial cell proliferation. Finally, perivascular mononuclear inflammation did not become evident until 48 h of treatment, and its presence correlated spatially and temporally with the gross and histological remodelling of newly formed capillary cords into larger blood vessels. In summary, these data suggest that, in the chicken CAM, TGF beta 1 initiates a sequence of cellular responses that results in growth inhibition, cellular accumulation through migration, and microvascular angiogenesis.
Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
E Y
EY
Yang
H L
HL
Moses
D000482:Allantois / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D002642:Chick Embryo; D002823:Chorion / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D005321:Extraembryonic Membranes / Q000166:cytology*; D005346:Fibroblast Growth Factors / Q000494:pharmacology; D007700:Kinetics; D046911:Macromolecular Substances; D009389:Neovascularization, Pathologic; D011994:Recombinant Proteins / Q000494:pharmacology; D013997:Time Factors; D015291:Transforming Growth Factors / Q000494:pharmacology*
D046911:Macromolecular Substances; D011994:Recombinant Proteins; D005346:Fibroblast Growth Factors; D015291:Transforming Growth Factors